The short version. Viviscal is the category’s best-studied oral hair supplement, with multiple brand-funded but published trials showing modest, real improvements in terminal hair counts over three-to-six months in women with diffuse thinning. It runs $40–50 per month, does not match topical minoxidil for efficacy, and is not the intervention most people with progressing hair loss actually need. For a woman with mild thinning and a normal medical workup who wants an OTC daily option, it’s a defensible six-month trial.

Viviscal is the most recognized oral hair-growth supplement in the English-speaking world. Owned by Church & Dwight since 2017, sold over-the-counter at major pharmacies, prescribed informally by dermatologists who prefer nutraceuticals to nothing, and backed by a series of brand-commissioned clinical trials that have kept the product defensibly on-shelf for three decades. It is also the progenitor of a category — the marine-protein-complex hair supplement — that now includes Nutrafol, Hush & Hush, and a dozen smaller imitators.

Our editorial position after a long look at the evidence: Viviscal is better than no supplement, worse than topical minoxidil, and priced at a level where its evidence-per-dollar argument is thinner than the brand’s dermatology-office positioning suggests. It is not a waste of money for the right reader. It is not the intervention most people with active hair loss actually need.

What Viviscal actually is

Viviscal was developed in the 1980s by a Scandinavian marine biologist, Hans Wadstein, who observed that Inuit populations with marine-protein-rich diets appeared to have thicker hair than matched European populations, and hypothesized that a specific marine protein complex might support hair growth. The resulting product, marketed as AminoMar C, is a proprietary blend of shark powder and mollusk powder (specifically, dogfish cartilage and oyster powder) combined with vitamin C, biotin, zinc, iron, niacin, and a few other cofactors. The modern formulation has been refined but retains AminoMar at its core.

The brand sells three product tiers. Viviscal Extra Strength is the consumer-facing product, sold at drugstores and online for roughly $40 per month. Viviscal Professional is a higher-dose formulation sold through dermatology and trichology offices for roughly $50 per month. Viviscal Man is a rebranded version of Extra Strength with identical actives and different packaging.

What distinguishes Viviscal from most hair supplements is that the brand has funded a series of small-to-moderate clinical trials on its own formulation, rather than relying exclusively on theoretical claims about individual ingredients. Those trials matter, and they are also what a reader evaluating the product needs to read carefully.

What the Viviscal clinical trials actually show

Viviscal has been the subject of perhaps a dozen published clinical trials over the past two decades, most of them funded by the brand or its predecessor company. A representative summary:

The trials consistently demonstrate a statistically significant improvement in terminal hair counts relative to placebo over three to six months of daily use, in women with self-reported thinning. The effect size is modest — typically in the range of 30 to 40 additional terminal hairs per defined scalp area, compared to placebo — and the blinded hair-count endpoints are generally conducted in a specific scalp region rather than across the full head.

What the trials do not demonstrate: superiority over topical minoxidil, effect in men with androgenetic alopecia (the evidence base is almost entirely in women), effect on scalp density visible to an unaided observer rather than to a trichoscope, or durability of effect after discontinuation.

The honest read is that Viviscal produces a real, measurable, modest increase in terminal hair counts over several months in women with diffuse thinning not driven by androgenetic alopecia — and that the effect is smaller than what topical minoxidil produces, and that the effect is conditional on continued use. This is not nothing. It is also not the transformation the brand’s direct-to-consumer marketing implies.

What the marine complex is probably doing

The mechanistic story for AminoMar is less settled than the clinical story. The brand’s position is that the marine proteins provide specific amino acids and bioavailable cofactors supporting keratin synthesis and follicle health. The skeptical read, which we find more defensible, is that Viviscal is a well-chosen multivitamin-plus-protein product delivering iron, biotin, zinc, vitamin C, and complete protein to a population — women in their thirties through fifties — who frequently have marginal iron and protein intakes relative to what optimal hair growth requires. Under this reading, the marine proteins are a high-quality protein source rather than a unique active agent, and the effect is indirect: correcting subclinical deficiencies that were quietly constraining hair growth.

Both readings are consistent with the trial data. The second reading is consistent with the observation that a careful blood panel followed by targeted supplementation of deficient micronutrients often produces similar or better outcomes at a fraction of the cost.

The cost question

Viviscal Extra Strength runs $40 to $45 per month at retail. Viviscal Professional runs $50 per month. Both are two tablets daily. Over a twelve-month evaluation window — which is the realistic timeline for seeing supplement effects on hair growth — the reader is committing $480 to $600.

For the same spend, a reader could instead: (a) get a full blood panel including ferritin, vitamin D, TSH, and B12, (b) take a targeted supplement addressing any deficiency found, (c) pay out-of-pocket for a single dermatologist consultation, and (d) still have money left for a Nizoral rotation. That is a better sequence of interventions for a reader whose hair loss has not been medically worked up.

If the blood panel comes back clean and the dermatologist diagnoses androgenetic alopecia, Viviscal is still not the primary recommendation — topical minoxidil is, and oral minoxidil is increasingly the secondary choice from dermatology practices when topical compliance is poor. Viviscal in that context is an adjunct, not a treatment.

Who it might actually be a good fit for

Women with diffuse thinning not explained by a specific medical workup who want an over-the-counter, low-risk daily intervention that requires no prescription and no commitment to a topical regimen. If the alternative is nothing, Viviscal is measurably better than nothing, and the side-effect profile is benign for most users.

Women in the postpartum six-to-twelve-month shedding window, as a gentle supporting intervention. The evidence base for supplement interventions in this specific context is limited (postpartum shedding resolves on its own), but Viviscal is not contraindicated and may marginally accelerate the return to baseline.

Women whose dermatologist has explicitly recommended it, often as part of a regimen that includes topical minoxidil. In this case the supplement is an adjunct and the math works out: a modest incremental benefit on top of the primary treatment.

Who it is not the right fit for

Anyone with active, progressing androgenetic alopecia using Viviscal as a primary intervention. The category-leader here is topical minoxidil, and substituting a supplement for minoxidil is how a reader ends up with six to twelve months of accumulated miniaturization that could have been prevented.

Anyone with an undiagnosed medical cause for their hair loss. Iron deficiency, thyroid dysfunction, and polycystic ovary syndrome are common drivers of diffuse female thinning, and each is better treated directly than papered over with a multivitamin-plus-protein product.

Men with classic pattern hair loss. The Viviscal evidence base in men is thin, the mechanism doesn’t target the androgen pathway, and the dollars are better spent on topical finasteride or oral minoxidil.

Side effects and durability

Viviscal is well-tolerated by most users. The most common side effect is mild gastrointestinal discomfort when taken on an empty stomach, which is usually resolved by taking the tablets with food. A small proportion of users with shellfish allergies should not take Viviscal; the oyster and mollusk content is real, and the allergen disclosure on the label is accurate.

On durability: like every supplement intervention, the effect persists only with continued use. Discontinuing Viviscal returns hair-count endpoints to baseline within several months. This is not a defect — it is how supplements work — but the brand’s marketing soft-sells the lifetime-commitment implication of the product.

Our recommendation

If you are a woman with mild-to-moderate diffuse thinning, you have done a baseline medical workup with normal results, you want a low-risk over-the-counter option, and you have the budget, Viviscal Extra Strength is a defensible choice for a six-month trial. Pair it with a twice-weekly Nizoral rotation and assess at month six with before/after photos under consistent lighting.

If you have not done a medical workup, do that first. A blood panel is cheaper than Viviscal and will often identify a treatable deficiency that a supplement can only partially address.

If your hair loss is significant or accelerating, skip the supplement conversation entirely and get a dermatology appointment on the calendar. Nothing we’ve written about Viviscal should suggest it is a substitute for topical minoxidil in a patient for whom minoxidil is appropriate.

This review was last evaluated against current evidence and re-priced on April 22, 2026. It supersedes our earlier versions. For the broader context on women’s hair-loss interventions, see our best hair loss shampoos for women roundup. For how we evaluate products, see our methodology.